Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Share :

ESMO 21st World Congress on Gastrointestinal Cancer

3 - 7 Jul 2019
Centre de Convencions International de Barcelona, Barcelona, Spain

Immunotherapy with radiation in metastatic pancreatic and colorectal adenocarcinoma

Dr Aparna Parikh - Massachusetts General Hospital Cancer Center, Boston, USA
Immunotherapy with radiation in metastatic pancreatic and colorectal adenocarcinoma ( Dr Aparna Parikh - Massachusetts General Hospital Cancer Center, Boston, USA )
15 Jul 2019

Using ctDNA to predict recurrence and response in colorectal cancer

Dr Aparna Parikh - Massachusetts General Hospital Cancer Center, Boston, USA
Using ctDNA to predict recurrence and response in colorectal cancer ( Dr Aparna Parikh - Massachusetts General Hospital Cancer Center, Boston, USA )
15 Jul 2019

Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer

Prof Ralf-Dieter Hofheinz - Uniklinik Mannheim, Mannheim, Germany
Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer ( Prof Ralf-Dieter Hofheinz - Uniklinik Mannheim, Mannheim, Germany )
15 Jul 2019

Applied precision cancer medicine in advanced biliary tract cancer

Dr Hossein Taghizadeh - Medical University of Vienna, Vienna, Austria
Applied precision cancer medicine in advanced biliary tract cancer ( Dr Hossein Taghizadeh -  Medical University of Vienna, Vienna, Austria )
15 Jul 2019

Treating HER2-mutant advanced biliary tract cancer with neratinib

Dr James Harding - Memorial Sloan kettering Cancer Center, New York, USA
Treating HER2-mutant advanced biliary tract cancer with neratinib ( Dr James Harding - Memorial Sloan kettering Cancer Center, New York, USA )
15 Jul 2019

CAPTEM vs FOLFIRI as second-line treatment for mCRC patients

Dr Filippo Pietrantonio - ‎IRCCS Istituto Nazionale dei Tumori Foundation, Milan, Italy
CAPTEM vs FOLFIRI as second-line treatment for mCRC patients ( Dr Filippo Pietrantonio - ‎IRCCS Istituto Nazionale dei Tumori Foundation, Milan, Italy )
15 Jul 2019

VOLTAGE: Use of nivolumab monotherapy and radical surgery in patients with locally advanced rectal cancer

Dr Takayuki Yoshino - National Cancer Center Hospital East in Chiba, Japan
VOLTAGE: Use of nivolumab monotherapy and radical surgery in patients with locally advanced rectal cancer ( Dr Takayuki Yoshino - National Cancer Center Hospital East in Chiba, Japan )
15 Jul 2019

TRIBE2: Latest data for patients with mCRC

Dr Chiara Cremolini - Università di Pisa, Pisa, Italy
TRIBE2: Latest data for patients with mCRC ( Dr Chiara Cremolini - Università di Pisa, Pisa, Italy )
15 Jul 2019

Entrectinib in NTRK-fusion positive gastrointestinal cancers

Prof Salvatore Siena - Università degli Studi di Milano Statale, Milan, Italy
Entrectinib in NTRK-fusion positive gastrointestinal cancers ( Prof Salvatore Siena - Università degli Studi di Milano Statale, Milan, Italy )
15 Jul 2019

Latest results from KEYNOTE-181: Pembrolizumab versus chemotherapy as a second-line therapy for advanced oesophageal cancer

Prof Jean-Philippe Metges - Centre Hospitalier Régional et Universitaire de Brest, Brest, France
Latest results from KEYNOTE-181: Pembrolizumab versus chemotherapy as a second-line therapy for advanced oesophageal cancer ( Prof Jean-Philippe Metges - Centre Hospitalier Régional et Universitaire de Brest, Brest, France )
15 Jul 2019

Latest advances in pancreatic cancer treatment and impact on practice

Prof Eric Van Cutsem and Dr Talia Golan
Latest advances in pancreatic cancer treatment and impact on practice ( Prof Eric Van Cutsem and Dr Talia Golan )
10 Jul 2019